E38N interferon gamma polypeptide variants
US7232562B2 · kind B2 · utility
0Cited by
47References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2003 |
| Grant date | Jun 19, 2007 |
| Priority date | — |
| Expiry date | Jan 26, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A conjugate exhibiting interferon gamma activity and comprising at least one first non-polypeptide moiety covalently linked to an IFG polypeptide, the polypeptide comprising an amino acid sequence that differs from that of a parent IFNG polypeptide in at least one introduced and/or at least one removed amino acid residue comprising an attachment group for the non-polypeptide moiety. The conjugate may be used for treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.